Abstract
Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have